Umecrine Cognition
2006
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Later Stage VC
LATEST DEAL TYPE
$4.96M
LATEST DEAL AMOUNT
5
INVESTORS
Description
Developer of drugs against neurological disorders in the central nervous system designed to treat brain disorders. The company's pharmaceutical products focuses on finding treatments for neurological disorders in the central nervous system that are caused by endogenous CNS-active steroids (GABA-steroids), enabling healthcare industries to provide treatment that directly addresses the neurocognitive signs and symptoms of Hepatic encephalopathy (HE).
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
- Karolinska Institutet Science Park
- Fogdevreten 2
- 171 65 Solna
- Sweden
+46 08-524 000 00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Umecrine Cognition’s full profile, request a free trial.
Umecrine Cognition Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 22-Nov-2016 | $4.96M | 00.000 | Completed | Clinical Trials - General | |
| 1. Early Stage VC | Completed | Startup |
Umecrine Cognition Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Almi Invest | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Fort Knox Förvaring | Holding Company | Minority | 000 0000 | 000000 0 | ||
| Karolinska Development | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Norrlandsfonden | Lender/Debt Provider | Minority | 000 0000 | 000000 0 | ||
| Partnerinvest Norr | Venture Capital | Minority | 000 0000 | 000000 0 |
Umecrine Cognition Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Magnus Doverskog Ph.D | Chief Executive Officer | ||
| Torbjörn Bäckström MD | Chief Scientific Officer & Board Member |
Umecrine Cognition Board Members (7)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Andersen Blom | Self | Board Member | 000 0000 | |
| Bruce Scharschmidt Ph.D | Umecrine Cognition | Board Member | 000 0000 | |
| Kenth Bergström | Umecrine Cognition | Chairman | 000 0000 | |
| Terje Kalland Ph.D | Self | Board Member | 000 0000 | |
| Tomas Odergren Ph.D | Self | Board Member | 000 0000 |